首页> 外国专利> Use of an antagonist of vascular endothelial growth factor (VEGF) in combination with a Second Agent comprising a reducing Agent to treat a tumor of myeloid Cell resistant uN subject; and Method for tumor diagnosis.

Use of an antagonist of vascular endothelial growth factor (VEGF) in combination with a Second Agent comprising a reducing Agent to treat a tumor of myeloid Cell resistant uN subject; and Method for tumor diagnosis.

机译：血管内皮生长因子（VEGF）拮抗剂与包含还原剂的第二试剂联合用于治疗对髓细胞耐药的uN受试者的肿瘤的用途;和用于肿瘤诊断的方法。

页面导航

摘要
著录项
相似文献

摘要

Methods for the treatment of cancer with combination therapies that include anti-VEGF antibodies are provided. Methods for diagnosing resistant tumors are also provided.

机译：提供了用包括抗VEGF抗体的组合疗法治疗癌症的方法。还提供了诊断抗药性肿瘤的方法。

著录项

公开/公告号CL2007000876A1

专利类型
公开/公告日2008-02-08

原文格式PDF
申请/专利权人 GENENTECH INC.;
展开▼

申请/专利号CL20070000876
发明设计人 GERBER HANS-PETER;FERRARA NAPOLEONE;SHOJAEI FARBOD;ZHONG CUILING;BALDWIN MEGAN;
展开▼

申请日2007-03-29
分类号A61P35/00;A61P37/00;A61P37/02;G01N33/15;G01N33/48;G01N33/574;G01N33/577;
国家 CL
入库时间 2022-08-21 20:08:35

相似文献

专利
外文文献
中文文献